Advanced search×

Overcoming failure to repair demyelination in EAE: an important step towards neuroprotection in multiple sclerosis.

Ralf R Gold

J Neuroimmunol 170(1-2):1-2 (2005) PMID 16298433

DOI: 10.1016/j.jneuroim.2005.10.015
Version: za2963e q8za5 q8zbf q8zc6 q8zd3 q8ze7 q8zfa q8zg3
Buy PDF

Similar articles you may find interesting…

  1. Artificial placenta - Lung assist devices for term and preterm newborns with respiratory failure.
    Niels Rochow, Emily C Chan, and Christoph Fusch

    Int J Artif Organs (2013) PMID 23645582

    Respiratory insufficiency is a major cause of neonatal mortality and long-term morbidity, especially in very low birth weight infants. Today, non-invasive and mechanical ventilation are commonly accepted procedures to provide respiratory support to newborns, but they can reach their...
    Buy PDF
  2. New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis.
    Rina Aharoni

    Expert Rev Clin Immunol 9(5):423-40 (2013) PMID 23634737

    Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS that is heterogeneous in its clinical manifestation and progression, as well as in its pathological mechanisms. Animal models, in particular the various forms of experimental autoimmune encephalomyelitis, hav...
    Buy PDF
  3. Human growth hormone may be detrimental when used to accelerate recovery from acute tendon-bone interface injuries.
    Keith M Baumgarten, Harvey A Oliver, and Patrick Heiser

    J Bone Joint Surg Am 95(9):783-9 (2013) PMID 23636184

    There have been few scientific studies that have examined usage of human growth hormone to accelerate recovery from injury. The hypothesis of this study was that human growth hormone would accelerate tendon-to-bone healing compared with control animals treated with placebo in a rat m...
    Buy PDF